Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 691 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR Potential Value of ctDNA NGS-based Analysis of Imatinib Resistant Secondary KIT... January 10, 2024 Can Using a Microwave Cause Cancer? March 25, 2021 EMA Recommends Refusal of the Marketing Authorisation for Pexidartinib July 3, 2020 Durvalumab Modestly Improves Survival in Advanced Biliary Tract Cancer February 10, 2022 Load more HOT NEWS ΚΑΡΚΙΝΟΣ ΤΟΥ ΜΑΣΤΟΥ Experts Urge to Remove Care Inequalities for Adolescents and Young Adults... Survivors of Childhood Cancer are at Excess Risk of Late Mortality... For Some Women with Breast Cancer, Cost Influences Decisions about Surgery
